Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents
about
Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley FeverStructure and functionality in flavivirus NS-proteins: perspectives for drug designT-705 (favipiravir) inhibition of arenavirus replication in cell cultureNeurological approaches for investigating West Nile virus disease and its treatment in rodentsActivity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106Effect of T-705 treatment on western equine encephalitis in a mouse modelProgress on the development of therapeutics against West Nile virusMonoclonal antibody produced in plants efficiently treats West Nile virus infection in miceTreatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirinEffective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic FeverStructure and function of the Zika virus full-length NS5 proteinANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION.Antiviral strategies for pandemic and seasonal influenzaEfficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome VirusT-705 (favipiravir) activity against lethal H5N1 influenza A virusesDrug discovery technologies and strategies for Machupo virus and other New World arenaviruses.Favipiravir (T-705), a novel viral RNA polymerase inhibitor.Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease modelsBacks against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreakMaporal virus as a surrogate for pathogenic New World hantaviruses and its inhibition by favipiravir.Structural Analysis of Monomeric RNA-Dependent Polymerases: Evolutionary and Therapeutic ImplicationsLethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters.Ebola Virus Infection: Overview and Update on Prevention and Treatment.Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis.Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters.Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome.Highlights in antiviral drug research: antivirals at the horizon.Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication.Development of experimental and early investigational drugs for the treatment of Ebola virus infections.Extinction of West Nile virus by Favipiravir through lethal mutagenesis.Clinical Evaluation of Ebola Virus Disease Therapeutics.Treatment with a Nucleoside Polymerase Inhibitor Reduces Shedding of Murine Norovirus in Stool to Undetectable Levels without Emergence of Drug-Resistant Variants.Viruses in Rodent Colonies: Lessons Learned from Murine Noroviruses.Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2'-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases.Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase.Zika virus (ZIKV) Replication is Substantially Inhibited by Novel Favipiravir and Interferon-alpha Combination Regimens.Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.West Nile virus
P2860
Q21092271-5663BC91-B1D3-45DE-B8EF-6EB27C2F2A9FQ23011530-232BCC28-31D9-4811-B430-0C99F2077532Q24633241-C1C9C82E-1E4E-4B0E-B37F-33C3FF15DC3AQ27009096-C318D5F3-62C4-47FD-94B8-560005038E67Q27487527-B1F071BC-048D-4B9B-82A0-E42F9D629F1FQ27488864-06FDA199-66ED-4125-B9B2-C7FFCECFFB55Q27489893-948D7A44-394F-454F-9F1A-BB47A761019BQ27490937-EFD3D918-AFB7-4743-9853-B01C8F7D1129Q28474006-F09E98E6-E07D-4F78-987B-DE38A6E52362Q28477434-A82D1754-3971-482E-B44A-75746204815AQ29365369-0B819B1E-E105-4418-8D12-0657F082C1FFQ30404586-2CCE39CE-D4F5-4B4D-860A-790C7EFC8E2AQ30408116-FAB4226C-0910-4138-BF71-C2B4083A9DE5Q33433096-F53D390F-3C55-488F-932A-23EAB69D82FCQ33639979-AE1B6F45-CF8D-4E8E-B85B-975CEE9D16ABQ34274569-057CFC6F-E414-4392-81A2-EFB7C9B5E4E6Q34374652-344EED8A-8A6B-4D27-B13E-62B9A3A41601Q34432483-864042C2-8D8D-4887-818E-380DF4EF3847Q35598919-5680DFD3-6F82-41CD-B4BD-335DFC6AF72FQ35624775-4CA1659E-7223-4E23-98A2-CFA83A91D3DEQ35784542-78D42090-D7BF-43F7-A469-12FF7A477179Q36166222-31651119-A008-4C4D-A44A-367743500534Q36202563-93D2CF3D-9F27-4D3D-97A0-635D1325BF78Q36363253-613C90BF-F48C-4EE7-9C15-C31C157CD7CCQ36705853-7347455C-717C-4EC4-91DA-9312B7B5C168Q37120083-D454C3F1-5E76-478D-AEFC-0440443B48C0Q37263923-3A9A050D-1E87-4151-8728-4CC0E753D1E5Q38007145-B0CA288E-F099-4ACF-8E94-43DCC4E427F7Q38158967-47E1A138-B88F-425F-85D1-0BC288DD22D7Q38524949-9BFD49B0-F224-4F4C-9A4E-0CEE8816D4F9Q38605122-68D030CB-9BD5-4AD7-8E49-5E91FDE211F6Q38617605-428263DE-035E-47EF-98FA-B627055A17F6Q38741925-C2E87FAE-D4EE-4078-B654-778CC316F8B7Q38766728-0349ADAD-1DE4-4352-A63D-AD4766D83D10Q38833628-F6E0B8F7-5A26-4CEF-AF4E-9026D763DB66Q40044875-04A61731-EB71-412F-BEE3-1DF06D812498Q42110040-1C584EEE-36AE-4A93-88D0-9147327148C0Q43046770-C12A9BA6-AE63-48D1-9B1A-F4E3C4B0B3F3Q54256710-BD9CEF65-6AA9-4C0A-A3C0-19EE5816822CQ56932479-CCC2CB08-1DF8-497C-93E0-60542E9B2213
P2860
Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Efficacy of orally administere ...... ile virus infection in rodents
@ast
Efficacy of orally administere ...... ile virus infection in rodents
@en
Efficacy of orally administere ...... ile virus infection in rodents
@nl
type
label
Efficacy of orally administere ...... ile virus infection in rodents
@ast
Efficacy of orally administere ...... ile virus infection in rodents
@en
Efficacy of orally administere ...... ile virus infection in rodents
@nl
prefLabel
Efficacy of orally administere ...... ile virus infection in rodents
@ast
Efficacy of orally administere ...... ile virus infection in rodents
@en
Efficacy of orally administere ...... ile virus infection in rodents
@nl
P2093
P2860
P50
P3181
P1433
P1476
Efficacy of orally administere ...... ile virus infection in rodents
@en
P2093
Andrew J Christensen
Brandon S Taro
Yousuke Furuta
P2860
P3181
P356
10.1016/J.ANTIVIRAL.2008.07.009
P577
2008-12-01T00:00:00Z